4//SEC Filing
Busch Matthew C. 4
Accession 0001127602-25-008421
CIK 0000318154other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:56 PM ET
Size
4.8 KB
Accession
0001127602-25-008421
Insider Transaction Report
Form 4
AMGEN INCAMGN
Busch Matthew C.
VP, Finance & CAO
Transactions
- Award
Common Stock
2025-03-03+497→ 5,277 total
Footnotes (1)
- [F1]These shares include 100 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001987926
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 7:56 PM ET
- Size
- 4.8 KB